Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-To-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.39955
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Increase in Methotrexate Dose in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Infliximab

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2005English

Transition to Ustekinumab in Patients With Moderate-To-Severe Psoriasis and Inadequate Response to Methotrexate: A Randomized Clinical Trial (TRANSIT)

British Journal of Dermatology
DermatologyMedicine
2014English

Pms41 - Cost-Effectiveness Analysis of Tofacitinib in Combination With Methotrexate in the Treatment of Moderate to Severe Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis

Advances in Therapy
MedicinePharmacology
2020English

Genetic Polymorphisms in Key Methotrexate Pathway Genes Are Associated With Response to Treatment in Rheumatoid Arthritis Patients

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2012English

Preliminary Study to Identify the Predictive Factors for the Response to Methotrexate Therapy in Patients With Rheumatoid Arthritis

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2009English

A7.17 Microarray Gene Expression Profiling of Rheumatoid Arthritis Patients for Prediction of Response to Methotrexate Treatment

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Pms47 - Cost-Effectiveness of Tofacitinib Compared With Adalimumab in the Treatment of Moderate to Severe Rheumatoid Arthritis in Iran

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effectiveness of TNF Inhibitor Treatment With Various Methotrexate Doses in Patients With Rheumatoid Arthritis: Results From Clinical Practice

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy